Julia Valiente-Carrasco
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Prospective validation of a urine-based proteomics test for predicting clinically significant prostate cancer in biopsy-naïve patients.
Journal: British journal of cancer
Published: March 13, 2026
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2.
Journal: Cell communication and signaling : CCS
Published: September 12, 2025
miR-191-5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 01, 2025
Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate-Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence.
Journal: The Prostate
Published: January 11, 2025
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.
Journal: Molecular therapy. Oncology
Published: October 19, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.
Journal: Science advances
Published: October 02, 2024
Validation of a Urine-Based Proteomics Test to Predict Clinically Significant Prostate Cancer: Complementing mpMRI Pathway.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: August 16, 2024
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination.
Journal: Cancers
Published: December 16, 2022
The role of multiparametric magnetic resonance in active surveillance of a low-risk prostate cancer cohort from clinical practice.
Journal: The Prostate
Published: December 12, 2022
Serum biomarkers for diagnosis and characterization of prostate cancer.
Journal: Archivos espanoles de urologia
Published: March 25, 2022
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool.
Journal: Molecular therapy. Nucleic acids
Published: November 15, 2021
In1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate Cancer.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 13, 2021
Last Updated: 09/26/2026